Cosmos Health Inc. (COSM) stock
COSMNasdaqWholesale-Drugs, Proprietaries & Druggists' SundriesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 18, 2026Score 4/30107% above fair value
$2.95+0.10 (+3.51%)
Close on Nov 18, 2026Market cap $296.87MP/E –Yield –
Cosmos Health revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Cosmos Health's revenue for the twelve months ending Jun 30, 2026 was $73.73M, up 33.8% year over year. For fiscal 2025 it was $65.27M, up 19.9% from the year before. Over ten years it grew 61.7% a year on average. The highest annual figure on record is $65.27M in fiscal 2025.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $65.27M | +19.9% |
| FY2024 | Dec 31, 2024 | $54.43M | +2.0% |
| FY2023 | Dec 31, 2023 | $53.38M | +6.0% |
| FY2022 | Dec 31, 2022 | $50.35M | -10.5% |
| FY2021 | Dec 31, 2021 | $56.24M | +1.5% |
| FY2020 | Dec 31, 2020 | $55.41M | +39.6% |
| FY2019 | Dec 31, 2019 | $39.68M | +7.0% |
| FY2018 | Dec 31, 2018 | $37.08M | +23.6% |
| FY2017 | Dec 31, 2017 | $30.01M | +344.3% |
| FY2016 | Dec 31, 2016 | $6.76M | +1165.5% |
| FY2015 | Dec 31, 2015 | $533.80K | -93.0% |
| FY2014 | Dec 31, 2014 | $7.64M | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $18.99M | +28.8% |
| Q1 FY2026 | Mar 31, 2026 | $17.93M | +30.7% |
| Q4 FY2025 | Dec 31, 2025 | $19.70M | +38.5% |
| Q3 FY2025 | Sep 30, 2025 | $17.11M | +37.9% |
| Q2 FY2025 | Jun 30, 2025 | $14.75M | +11.7% |
| Q1 FY2025 | Mar 31, 2025 | $13.71M | -6.0% |
| Q4 FY2024 | Dec 31, 2024 | $14.22M | -10.2% |
| Q3 FY2024 | Sep 30, 2024 | $12.41M | -3.2% |
| Q2 FY2024 | Jun 30, 2024 | $13.21M | +6.8% |
| Q1 FY2024 | Mar 31, 2024 | $14.58M | +18.1% |
| Q4 FY2023 | Dec 31, 2023 | $15.84M | +31.4% |
| Q3 FY2023 | Sep 30, 2023 | $12.82M | +6.7% |
| Q2 FY2023 | Jun 30, 2023 | $12.36M | -6.4% |
| Q1 FY2023 | Mar 31, 2023 | $12.35M | -5.5% |
| Q4 FY2022 | Dec 31, 2022 | $12.05M | -25.5% |
| Q3 FY2022 | Sep 30, 2022 | $12.02M | +3.4% |
| Q2 FY2022 | Jun 30, 2022 | $13.21M | -19.0% |
| Q1 FY2022 | Mar 31, 2022 | $13.07M | -8.9% |
| Q4 FY2021 | Dec 31, 2021 | $16.18M | +26.2% |
| Q1 FY2021 | Mar 31, 2021 | $11.62M | -2.6% |
| Q4 FY2020 | Dec 31, 2020 | $16.30M | +38.2% |
| Q3 FY2020 | Sep 30, 2020 | $14.35M | +48.2% |
| Q2 FY2020 | Jun 30, 2020 | $12.82M | +50.6% |
| Q1 FY2020 | Mar 31, 2020 | $11.93M | +23.2% |
| Q4 FY2019 | Dec 31, 2019 | $11.79M | +52.1% |
| Q3 FY2019 | Sep 30, 2019 | $9.69M | +13.8% |
| Q2 FY2019 | Jun 30, 2019 | $8.51M | -3.9% |
| Q1 FY2019 | Mar 31, 2019 | $9.68M | -19.1% |
| Q4 FY2018 | Dec 31, 2018 | $7.75M | -24.3% |
| Q3 FY2018 | Sep 30, 2018 | $8.51M | -10.9% |
| Q2 FY2018 | Jun 30, 2018 | $8.86M | +44.9% |
| Q1 FY2018 | Mar 31, 2018 | $11.97M | +190.7% |
| Q4 FY2017 | Dec 31, 2017 | $10.24M | +215.1% |
| Q3 FY2017 | Sep 30, 2017 | $9.55M | +574.9% |
| Q2 FY2017 | Jun 30, 2017 | $6.11M | +539.5% |
| Q1 FY2017 | Mar 31, 2017 | $4.12M | – |
| Q4 FY2016 | Dec 31, 2016 | $3.25M | – |
| Q3 FY2016 | Sep 30, 2016 | $1.41M | – |
| Q2 FY2016 | Jun 30, 2016 | $955.90K | – |
See a number that looks wrong?